China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)
China · Delayed Price · Currency is CNY 25.28
+0.37 (1.49%)
Oct 30, 2026, 3:04 PM CST
SHE:000999 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 42,071 | 47,364 | 56,946 | 49,142 | 46,264 | 33,518 | |
Market Cap Growth | -12.19% | -16.83% | 15.88% | 6.22% | 38.03% | 37.29% |
Enterprise Value | 54,710 | 60,542 | 56,320 | 49,886 | 41,955 | 29,968 |
Last Close Price | 25.28 | 27.32 | 32.00 | 26.34 | 24.40 | 17.45 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 13.03 | 13.85 | 16.91 | 17.23 | 18.89 | 16.31 |
Forward PE | 8.21 | 9.40 | 16.06 | 23.84 | 21.67 | 23.31 |
PS Ratio | 1.36 | 1.50 | 2.06 | 1.99 | 2.56 | 2.16 |
PB Ratio | 1.09 | 1.23 | 2.26 | 2.03 | 2.64 | 2.13 |
P/TBV Ratio | 4.40 | 5.16 | 5.00 | 4.73 | 4.35 | 3.74 |
P/FCF Ratio | 12.07 | 11.17 | 15.77 | 14.74 | 22.52 | 33.12 |
P/OCF Ratio | 8.61 | 8.59 | 12.94 | 11.72 | 15.39 | 17.78 |
PEG Ratio | - | 1.18 | 1.07 | 1.33 | 1.22 | 1.36 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 1.76 | 1.92 | 2.04 | 2.02 | 2.32 | 1.93 |
EV/EBITDA Ratio | 9.30 | 11.09 | 11.66 | 11.80 | 12.91 | 11.34 |
EV/EBIT Ratio | 12.39 | 13.67 | 13.44 | 14.08 | 15.07 | 13.54 |
EV/FCF Ratio | 15.69 | 14.27 | 15.59 | 14.96 | 20.42 | 29.61 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.10 | 0.17 | 0.05 | 0.12 | 0.02 | 0.02 |
Debt / EBITDA Ratio | 0.68 | 1.15 | 0.26 | 0.69 | 0.12 | 0.09 |
Debt / FCF Ratio | 1.15 | 1.51 | 0.36 | 0.90 | 0.19 | 0.23 |
Net Debt / Equity Ratio | -0.09 | -0.08 | -0.21 | -0.22 | -0.16 | -0.26 |
Net Debt / EBITDA Ratio | -0.61 | -0.57 | -1.12 | -1.24 | -0.85 | -1.53 |
Net Debt / FCF Ratio | -1.00 | -0.74 | -1.50 | -1.57 | -1.34 | -4.00 |
Asset Turnover | 0.55 | 0.64 | 0.69 | 0.74 | 0.70 | 0.67 |
Inventory Turnover | 2.16 | 2.61 | 2.68 | 3.07 | 3.43 | 3.18 |
Quick Ratio | 1.45 | 1.34 | 1.15 | 1.25 | 1.02 | 1.23 |
Current Ratio | 2.04 | 1.83 | 1.61 | 1.74 | 1.38 | 1.60 |
Return on Equity (ROE) | 10.16% | 13.07% | 15.26% | 15.19% | 14.99% | 14.07% |
Return on Assets (ROA) | 4.93% | 5.60% | 6.53% | 6.58% | 6.73% | 5.94% |
Return on Invested Capital (ROIC) | 10.40% | 13.75% | 17.73% | 17.72% | 17.71% | 17.45% |
Return on Capital Employed (ROCE) | 10.30% | 10.20% | 15.80% | 13.00% | 15.10% | 13.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 7.67% | 7.22% | 5.91% | 5.80% | 5.29% | 6.13% |
FCF Yield | 8.29% | 8.96% | 6.34% | 6.78% | 4.44% | 3.02% |
Dividend Yield | 3.98% | 3.65% | 2.98% | 3.02% | 2.14% | 2.49% |
Payout Ratio | 56.91% | 36.71% | 84.16% | 37.01% | 34.95% | 24.61% |
Buyback Yield / Dilution | 0.00% | 0.40% | -0.25% | 0.33% | -0.90% | 0.15% |
Total Shareholder Return | 3.98% | 4.05% | 2.73% | 3.35% | 1.24% | 2.64% |